Strengthens management team with appointment of Steven Powell London, UK, 15 October 2013: SEEK, a privately-owned UK pharmaceutical group, announces that it has been awarded a prestigious European Union Framework Programme 7 grant to advance the development of its universal flu immunotherapeutic, FLU-v.
http://www.drugs.com/clinical_trials/seek-awarded-fp7-grant-fund-phase-iib-trial-universal-flu-immunotherapeutic-16226.html?
http://www.drugs.com/clinical_trials/seek-awarded-fp7-grant-fund-phase-iib-trial-universal-flu-immunotherapeutic-16226.html?
No comments:
Post a Comment